[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ScorpionFund Scorpion Capital Scorpion Capital posts on X about $slno, tokyo, market cap, reduce the most. They currently have XXXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1341860594387877888/interactions)  - X Week XXXXX +459% - X Month XXXXXX -XX% - X Months XXXXXXX -XX% - X Year XXXXXXXXX -XX% ### Mentions: X [#](/creator/twitter::1341860594387877888/posts_active)  - X Week X -XX% - X Month XX -XX% - X Months XX +23% - X Year XX +65% ### Followers: XXXXXX [#](/creator/twitter::1341860594387877888/followers)  - X Week XXXXXX -XXXX% - X Month XXXXXX -XXXX% - X Months XXXXXX +0.10% - X Year XXXXXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1341860594387877888/influencer_rank)  ### Social Influence **Social category influence** [travel destinations](/list/travel-destinations) XX% [finance](/list/finance) XX% **Social topic influence** [$slno](/topic/$slno) #2, [tokyo](/topic/tokyo) 25%, [market cap](/topic/market-cap) 25%, [reduce](/topic/reduce) 25%, [$6920t](/topic/$6920t) 25%, [$14b](/topic/$14b) 25%, [$100200mm](/topic/$100200mm) 25%, [we will](/topic/we-will) XX% **Top accounts mentioned or mentioned by** [@jfais20](/creator/undefined) [@bioadvo](/creator/undefined) [@threadanddoc](/creator/undefined) [@joinyellowbrick](/creator/undefined) [@seedy19tron](/creator/undefined) [@pharmdca](/creator/undefined) [@breakoutpoint](/creator/undefined) **Top assets mentioned** [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) ### Top Social Posts Top posts by engagements in the last XX hours "Lasertec $6920 (Tokyo) latest quarter is quite the crash and burn. Consistent with a fraud in the final throes. It's down substantially since our report but still $14B market cap vs. $100-200MM prior to becoming a story stock. Look out below. Where do we start -"We will no longer disclose the quarterlyresultsof orders and order backlog" -"Shareholders and investors have asked us to reduce short term share price volatility by not disclosing orders on a quarterlybasis"; interesting as orders are the main figure investors care about. -Sales fell year over year and sequentially esp equipment" [X Link](https://x.com/ScorpionFund/status/1852071589447373112) 2024-10-31T19:34Z 84.8K followers, 20.6K engagements "1/2 $SLNO Soleno Therapeutics. Our thoughts aheadof earningstoday: X. We don't think this quarter is particularly critical - the rubber meets the road in the next couple of quarters. VYKAT XR became commercially available in April. This quarter just reflects the initial bolus of patients - the new restaurant effect a short-term tailwind given the number of desperate families willing to try anything. Patients and doctors are willing to give any new drug a try for 3-6 months in some cases longer before throwing in the towel. We spoke with enough trial investigators who indicated close to a 100%" [X Link](https://x.com/ScorpionFund/status/1985811855550329197) 2025-11-04T20:50Z 84.8K followers, 40.8K engagements "$SLNO Soleno Therapeutics earnings call was a farce. We've never seen a short report mentioned so many times by mgmt and sell-side. Only scams tend to engage with short reports. Credible companies don't bother. X. The attempt to blame our report for a slowdown in start forms is amusing and disingenuous in the context of a dirty drug that failed its Phase X trial (); not to mention the fatality of a young patient who had recently started the drug. Our report simply documented pre-existing reports of hospitalizations for heart failure in kids who had recently started the drug among various" [X Link](https://x.com/ScorpionFund/status/1986074886830170354) 2025-11-05T14:15Z 84.8K followers, 36.5K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ScorpionFund Scorpion Capital
Scorpion Capital posts on X about $slno, tokyo, market cap, reduce the most. They currently have XXXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +459%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX -XX%
Mentions: X #
- X Week X -XX%
- X Month XX -XX%
- X Months XX +23%
- X Year XX +65%
Followers: XXXXXX #
- X Week XXXXXX -XXXX%
- X Month XXXXXX -XXXX%
- X Months XXXXXX +0.10%
- X Year XXXXXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence travel destinations XX% finance XX%
Social topic influence $slno #2, tokyo 25%, market cap 25%, reduce 25%, $6920t 25%, $14b 25%, $100200mm 25%, we will XX%
Top accounts mentioned or mentioned by @jfais20 @bioadvo @threadanddoc @joinyellowbrick @seedy19tron @pharmdca @breakoutpoint
Top assets mentioned Soleno Therapeutics, Inc. Common Stock (SLNO)
Top Social Posts
Top posts by engagements in the last XX hours
"Lasertec $6920 (Tokyo) latest quarter is quite the crash and burn. Consistent with a fraud in the final throes. It's down substantially since our report but still $14B market cap vs. $100-200MM prior to becoming a story stock. Look out below. Where do we start -"We will no longer disclose the quarterlyresultsof orders and order backlog" -"Shareholders and investors have asked us to reduce short term share price volatility by not disclosing orders on a quarterlybasis"; interesting as orders are the main figure investors care about. -Sales fell year over year and sequentially esp equipment"
X Link 2024-10-31T19:34Z 84.8K followers, 20.6K engagements
"1/2 $SLNO Soleno Therapeutics. Our thoughts aheadof earningstoday: X. We don't think this quarter is particularly critical - the rubber meets the road in the next couple of quarters. VYKAT XR became commercially available in April. This quarter just reflects the initial bolus of patients - the new restaurant effect a short-term tailwind given the number of desperate families willing to try anything. Patients and doctors are willing to give any new drug a try for 3-6 months in some cases longer before throwing in the towel. We spoke with enough trial investigators who indicated close to a 100%"
X Link 2025-11-04T20:50Z 84.8K followers, 40.8K engagements
"$SLNO Soleno Therapeutics earnings call was a farce. We've never seen a short report mentioned so many times by mgmt and sell-side. Only scams tend to engage with short reports. Credible companies don't bother. X. The attempt to blame our report for a slowdown in start forms is amusing and disingenuous in the context of a dirty drug that failed its Phase X trial (); not to mention the fatality of a young patient who had recently started the drug. Our report simply documented pre-existing reports of hospitalizations for heart failure in kids who had recently started the drug among various"
X Link 2025-11-05T14:15Z 84.8K followers, 36.5K engagements